Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Colorectal Neoplasms and ERBB3[original query] |
---|
Molecular characterization of circulating colorectal tumor cells defines genetic signatures for individualized cancer care. Oncotarget 2017 10 8 (40): 68026-68037. Kong Say Li, Liu Xingliang, Suhaimi Nur-Afidah Mohamed, Koh Kenneth Jia Hao, Hu Min, Lee Daniel Yoke San, Cima Igor, Phyo Wai Min, Lee Esther Xing Wei, Tai Joyce A, Foong Yu Miin, Vo Jess Honganh, Koh Poh Koon, Zhang Tong, Ying Jackie Y, Lim Bing, Tan Min-Han, Hillmer Axel |
Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study. Current oncology (Toronto, Ont.) 2017 1 23 (6): e571-e575. Sheffield B S, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones S J M, Lim H J, Renouf D J, Huntsman D G, Yip S, Laskin J, Marra M, Schaeffer D |
Molecular Landscape of ERBB2/ERBB3 Mutated Colorectal Cancer. Journal of the National Cancer Institute 2018 Apr . Loree Jonathan M, Bailey Ann M, Johnson Amber M, Yu Yao, Wu Wenhui, Bristow Christopher A, Davis Jennifer S, Shaw Kenna R, Broaddus Russell, Banks Kimberly C, Lanman Richard B, Meric-Bernstam Funda, Overman Michael J, Kopetz Scott, Raghav Kanw |
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Mar . Hill Andrew G, Findlay Michael P, Burge Matthew E, Jackson Christopher, Alfonso Pilar Garcia, Samuel Leslie, Ganju Vinod, Karthaus Meinolf, Amatu Alessio, Jeffery Mark, Bartolomeo Maria Di, Bridgewater John, Coveler Andrew L, Hidalgo Manuel, Kapp Amy V, Sufan Roxana I, McCall Bruce B, Hanley William D, Penuel Elicia M, Pirzkall Andrea, Tabernero Jos |
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3. Cancer 2018 Jan . Ross Jeffrey S, Fakih Marwan, Ali Siraj M, Elvin Julia A, Schrock Alexa B, Suh James, Vergilio Jo-Anne, Ramkissoon Shakti, Severson Eric, Daniel Sugganth, Fabrizio David, Frampton Garrett, Sun James, Miller Vincent A, Stephens Philip J, Gay Laurie |
Exome sequencing of 22 genes using tissue from patients with biliary tract cancer. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2019 Oct . Høgdall Dan, Larsen Ole F, Linnemann Dorte, Svenstrup Poulsen Tim, Høgdall Estrid |
Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti-EGFR-Based Therapy. JCO precision oncology 2022 5 6 e2200037. Randon Giovanni, Maddalena Giulia, Germani Marco Maria, Pircher Chiara Carlotta, Manca Paolo, Bergamo Francesca, Giordano Mirella, Sposetti Caterina, Montagna Aldo, Vetere Guglielmo, Zambelli Luca, Rasola Cosimo, Boccaccino Alessandra, Pagani Filippo, Ambrosini Margherita, Massafra Marco, Fontanini Gabriella, Milione Massimo, Fassan Matteo, Cremolini Chiara, Lonardi Sara, Pietrantonio Filip |
Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients. Cancers 2023 1 15 (1): . Hsieh Yung-Yu, Kuo Wen-Lin, Hsu Wan-Ting, Tung Shui-Yi, Li Ch |
Multigene Panel Next-Generation Sequencing Techniques in the Management of Patients with Metastatic Colorectal Carcinoma: The Way Forward for Personalized Treatment? A Single-Center Experience. International journal of molecular sciences 2024 10 25 (20): . Laura Matteucci, Francesco Giulio Sullo, Chiara Gallio, Luca Esposito, Margherita Muratore, Ilario Giovanni Rapposelli, Daniele Calistri, Elisabetta Petracci, Claudia Rengucci, Laura Capelli, Elisa Chiadini, Paola Ulivi, Alessandro Passardi, Alessandro Bitto |
CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
- Page last reviewed:Feb 1, 2024
- Content source: